These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23750345)

  • 21. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
    Rogers KA; Huang Y; Ruppert AS; Salem G; Stephens DM; Heerema NA; Andritsos LA; Awan FT; Byrd JC; Flynn JM; Maddocks KJ; Jones JA
    Br J Haematol; 2018 Jan; 180(2):259-266. PubMed ID: 29193006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic lymphocytic leukemia and Hodgkin's disease. Clinicopathologic study of three cases with good prognosis.
    Serratrice De Roux C; Coso D; Bouabdallah R; Serratrice J; Disdier P; Weiller PJ
    Haematologica; 2000 Aug; 85(8):878-9. PubMed ID: 10942943
    [No Abstract]   [Full Text] [Related]  

  • 23. How I Manage Chronic Lymphocytic Leukemia in 2014.
    Alwbari A; Makhoul I
    J Ark Med Soc; 2016 Feb; 112(10):187-8. PubMed ID: 26939472
    [No Abstract]   [Full Text] [Related]  

  • 24. Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect
    Flowers CR; Nabhan C; Kay NE; Mato A; Lamanna N; Farber CM; Davids MS; Kiselev P; Swern AS; Sullivan K; Flick ED; Sharman JP
    Leuk Lymphoma; 2018 Oct; 59(10):2327-2335. PubMed ID: 29415595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lymphocytic leukemia (CLL)-Then and now.
    Rai KR; Jain P
    Am J Hematol; 2016 Mar; 91(3):330-40. PubMed ID: 26690614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia.
    Miller CR; Ruppert AS; Fobare S; Chen TL; Liu C; Lehman A; Blachly JS; Zhang X; Lucas DM; Grever MR; Tallman MS; Flinn IW; Rassenti LZ; Kipps TJ; Sampath D; Coombes KR; Hertlein EK
    Oncotarget; 2017 Apr; 8(16):25942-25954. PubMed ID: 28412730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-12 inhibits apoptosis in chronic lymphatic leukemia (CLL) B cells.
    Schuhknecht S; Duensing S; Dallmann I; Grosse J; Reitz M; Atzpodien J
    Cancer Biother Radiopharm; 2002 Oct; 17(5):495-9. PubMed ID: 12470418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group.
    Goede V; Bahlo J; Chataline V; Eichhorst B; Dürig J; Stilgenbauer S; Kolb G; Honecker F; Wedding U; Hallek M
    Leuk Lymphoma; 2016; 57(4):789-96. PubMed ID: 26377031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of chronic lymphocytic leukemia: achieving minimal residual disease-negative status as a goal.
    Montserrat E
    J Clin Oncol; 2005 May; 23(13):2884-5. PubMed ID: 15738532
    [No Abstract]   [Full Text] [Related]  

  • 30. Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study.
    Goede V; Fischer K; Engelke A; Schlag R; Lepretre S; Montero LF; Montillo M; Fegan C; Asikanius E; Humphrey K; Fingerle-Rowson G; Hallek M
    Leukemia; 2015 Jul; 29(7):1602-4. PubMed ID: 25634683
    [No Abstract]   [Full Text] [Related]  

  • 31. The rate of in vitro fludarabine-induced peripheral blood and bone marrow cell apoptosis may predict the chemotherapy outcome in patients with chronic lymphocytic leukemia.
    Podhorecka M; Klimek P; Chocholska S; Szymczyk A; Macheta A; Kowal M; Dmoszynska A; Hus M
    Eur J Clin Pharmacol; 2015 Sep; 71(9):1121-7. PubMed ID: 26141594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
    Colla S; Sammarelli G; Crugnola M; Ascani S; Sabbatini E; Bonomini S; Hojden M; Craviotto L; De Celis I; Morandi F; Caramatti C; Rizzoli V; Giuliani N
    Eur J Haematol; 2004 May; 72(5):361-5. PubMed ID: 15059073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms.
    Zhang W; Pelicano H; Yin R; Zeng J; Wen T; Ding L; Huang R
    Mol Med Rep; 2015 Nov; 12(5):7374-88. PubMed ID: 26458979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)].
    Ando S; Ando S; Otani N; Kanbe T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):153-6. PubMed ID: 8422181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin.
    Skribek H; Otvos R; Flaberg E; Nagy N; Markasz L; Eksborg S; Masszi T; Kozma A; Adam E; Miseta A; Klein E; Szekely L
    Exp Hematol; 2010 Dec; 38(12):1219-30. PubMed ID: 20837094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia.
    Buchner M; Fuchs S; Prinz G; Pfeifer D; Bartholomé K; Burger M; Chevalier N; Vallat L; Timmer J; Gribben JG; Jumaa H; Veelken H; Dierks C; Zirlik K
    Cancer Res; 2009 Jul; 69(13):5424-32. PubMed ID: 19549911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.
    Parikh SA; Habermann TM; Chaffee KG; Call TG; Ding W; Leis JF; Macon WR; Schwager SM; Ristow KM; Porrata LF; Kay NE; Slager SL; Shanafelt TD
    Am J Hematol; 2015 Apr; 90(4):334-8. PubMed ID: 25581025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of trisomy 12, t(14;18)(q32;q21), and t(8;14)(q24.1;q11.2) in a patient with B-cell chronic lymphocytic leukemia.
    Lau LC; Lim P; Lim YC; Teng LM; Lim TH; Lim LC; Tan SY; Lim ST; Sanger WG; Tien SL
    Cancer Genet Cytogenet; 2008 Sep; 185(2):95-101. PubMed ID: 18722878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia.
    Solman IG; Blum LK; Hoh HY; Kipps TJ; Burger JA; Barrientos JC; O'Brien S; Mulligan SP; Kay NE; Hillmen P; Byrd JC; Lal ID; Dean JP; Mongan A
    Leuk Res; 2020 Oct; 97():106432. PubMed ID: 32911375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells.
    Gross E; L'Faqihi-Olive FE; Ysebaert L; Brassac M; Struski S; Kheirallah S; Fournié JJ; Laurent G; Quillet-Mary A
    Leukemia; 2010 Nov; 24(11):1885-92. PubMed ID: 20827287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.